Search:
Latest News
|
22 May 2012
-1 Likes
The Food and Drug Administration Safety and Innovation Act (FDASIA), the Senate’s iteration of a package of user fee legislation and other regulatory reforms, advanced in the Senate on 21 May, moving
[Read More...]
Latest News
|
15 May 2012
0 Likes
A Senate hearing being held by Senator Bernie Sanders (I-VT) seeks to advance legislation that would create a prize fund for companies to create new medicines and vaccines, partially replacing the
[Read More...]
Latest News
|
14 May 2012
0 Likes
A new bill proposed in the US House of Representatives would require the Office of Information and Regulatory Affairs (OIRA) to compile a report every four years recommending certain regulatory
[Read More...]
Latest News
|
11 May 2012
0 Likes
In early 2011, several bills aiming to curb drug shortages were introduced in the US House of Representatives and the US Senate. Despite the bills’ bipartisan nature and widespread support, they’ve
[Read More...]
Latest News
|
10 May 2012
0 Likes
The House Energy and Commerce Committee advanced the Food and Drug Administration (FDA) Reform Act of 2012, a package of proposals to both fund and reform the agency, by a unanimous vote involving 46
[Read More...]
Latest News
|
10 May 2012
0 Likes
Explosive allegations have emerged from two prominent Senators regarding marketing tactics used by a number of pharmaceutical companies, including Purdue Pharma, Endo Pharmaceuticals and Johnson &
[Read More...]
Latest News
|
10 May 2012
0 Likes
The US House of Representatives’ Energy and Commerce Committee is set to hold a vote on Thursday, 10 May on a collection of user fee legislation being dubbed the Food and Drug Administration (FDA)
[Read More...]
Latest News
|
10 May 2012
0 Likes
A bipartisan bill introduced in the House of Representatives would work to speed up the development and review of some drugs intended to treat life-threatening diseases by creating a new “breakthrough
[Read More...]
Latest News
|
8 May 2012
0 Likes
The US House of Representatives’ Energy and Commerce Subcommittee on Health meets 8 May to conduct its markup process for various user fee bills, including the Prescription Drug User Fee Act (PDUFA)
[Read More...]
Latest News
|
1 May 2012
0 Likes
The Government Accountability Office (GAO), the government agency tasked with reviewing and auditing government programs, has found the US Food and Drug Administration (FDA) to be meeting its
[Read More...]